A Phase 2, Double-blind, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Oral Administration of Ganaxolone in Women With Postpartum Depression
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2018
At a glance
- Drugs Ganaxolone (Primary)
- Indications Postnatal depression
- Focus Adverse reactions; Therapeutic Use
- Acronyms Amaryllis
- Sponsors Marinus Pharmaceuticals
- 02 Aug 2018 According to a Marinus Pharmaceuticals media release, data from the open label phase are expected in the fourth quarter of 2018
- 13 Mar 2018 Planned number of patients changed from 50 to 58.
- 06 Mar 2018 According to a Marinus Pharmaceuticals media release, Status changed from planning to recruiting.